Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00542594

Acronym

ARIES

Enrollment

1840

Registered

2007-10-11

Start date

2005-11-30

Completion date

2011-06-30

Last updated

2013-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, anastrozole

Brief summary

The purpose of this survey is to describe long-term tolerance as seen under current conditions of use for anastrozole.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* woman treated with anastrozole as adjuvant therapy for hormone-dependant breast cancer in post-menopausal women with positive hormone-receptors

Outcome results